Go to Body

Risk stratification of gallbladder polyps larger than 10 mm using high-resolution ultrasonography and texture analysis.

페이지 정보

작성자 profile_imageadmin 작성일 19-04-18 16:09
425 0




To assess important features for risk stratification of gallbladder (GB) polyps >10 mm using high-resolution ultrasonography (HRUS) and texture analysis.


We included 136 patients with GB polyps (>10 mm) who underwent both HRUS and cholecystectomy (non-neoplastic, n = 58; adenomatous, n = 32; and carcinoma, n = 46). Two radiologists retrospectively assessed HRUS findings and texture analysis. Multivariate analysis was performed to identify significant predictors for neoplastic polyps and carcinomas.


Single polyp (OR, 3.680-3.856) and larger size (OR, 1.450-1.477) were independently associated with neoplastic polyps (p < 0.05). In a single or polyp >14 mm, sensitivity for differentiating neoplastic from non-neoplastic polyps was 92.3%. To differentiate carcinoma from adenoma, sessile shape (OR, 9.485-41.257), larger size (OR, 1.267-1.303), higher skewness (OR, 6.382) and lower grey-level co-occurrence matrices (GLCM) contrast (OR, 0.963) were significant predictors (p < 0.05). In a polyp >22 mm or sessile, sensitivity for differentiating carcinomas from adenomas was 93.5-95.7%. If a polyp demonstrated at least one HRUS finding and at least one texture feature, the specificity for diagnosing carcinoma was increased to 90.6-93.8%.


In a GB polyp >10 mm, single and diameter >14 mm were useful for predicting neoplastic polyps. In neoplastic polyps, sessile shape, diameter >22 mm, higher skewness and lower GLCM contrast were useful for predicting carcinoma.


• Risk of neoplastic polyp is low in <14 mm and multiple polyps

• A sessile polyp or >22 mm has increased risk for GB carcinomas 

• Higher skewness and lower GLCM contrast are predictors of GB carcinoma 

• HRUS is useful for risk stratification of GB polyps >1 cm.

KEYWORDS: Adenomatous polyp; Carcinoma; Gallbladder; Texture analysis; Ultrasound

  • Company Name ㅣ MEDICALIP
    CEO ㅣ Sang Joon Park    Tel ㅣ +82-2-2135-9148
    Business Registration Number ㅣ 406-81-04085
    Address ㅣ 7F, Changgyeong Building, 174, Yulgok-ro, Jongno-gu, Seoul, Republic of Korea
Copyright2018. MEDICAL IP. All Rights Reserved.